Lee KH, Lee JS, Sugawara S, Kang JH, et al. First-line nivolumab plus platinum chemotherapy and bevacizumab for advanced nonsquamous non-small cell lung cancer: A 3-year follow-up of the phase 3 randomized TASUKI-52 trial. Lung Cancer 2025;201:108109.
PMID: 39893774